This New Type 1 Treatment Might Actually Work

New Hope for Type-1 Diabetics? SAB-142 First Patient Dosed (Trial Update)
Imagine getting diagnosed with Type 1 and hearing there’s a new treatment that might help protect what’s left of your insulin production. That reality just got one step closer. In this video, we break down the major news from SAB Biotherapeutics: the first patient has officially been dosed in the SAFEGUARD Phase 2b trial for SAB-142.
This isn't just another research paper—this is a human trial happening right now that could change how we treat new-onset T1D forever.
video chapters:
0:00 - The New Hope for T1D
0:43 - Breaking News: First Patient Dosed (Dec 18, 2025)
1:30 - How the Immune Attack Destroys Beta Cells
2:12 - Why SAB-142 is Safer than Older Therapies (Rabbit ATG)
2:32 - The SAFEGUARD Phase 2b Trial Explained
3:52 - Real World Benefits: Less Insulin, Better Control?
4:09 - When Can We Expect Results? (Timeline)
5:44 - The Goal: Preserving Function at Diagnosis
about this video:
SAB-142 is a novel immunotherapy designed to stop the body's attack on its own insulin-producing beta cells. Unlike previous treatments that used animal-derived antibodies (like Rabbit ATG) which often caused serum sickness, SAB-142 is fully human. This means it aims to provide the same powerful protection with significantly fewer side effects.
If successful, this treatment wouldn't just be about "managing" diabetes—it would be about preserving the body's natural ability to make insulin, potentially leading to a "honeymoon phase" that lasts for years, fewer complications, and a much lighter burden of daily care.
related videos:
Watch my playlist on Type 1 Diabetes Research & News: [INSERT PLAYLIST LINK HERE]
medical disclaimer:
I am not a doctor. This video is for informational purposes only and should not be taken as medical advice. Always consult with your endocrinologist or primary care physician regarding your treatment options and before making any changes to your diabetes management plan.
about the channel:
Type-1 Diabetic Warriors is dedicated to the millions of people who struggle with Type-1 Diabetes. We provide information on how to live a normal life while stressing the importance of caring for this potentially lethal disease. We cover subjects such as Blood Sugar testing, Kidney disease, Heart Disease, Vision complications, and more. We teach you how to stay alive and thrive!
#SAB142 #SABBiotherapeutics #Type1Diabetes #Type1Diabetic #Diabetes #DiabetesTreatment #ClinicalTrials #Type1DiabetesCure #T1DResearch
We're providing an update on SAB Biotherapeutics' SAP 142 therapy, vital for diabetes treatment and beta cell insulin secretion. This new sabs news highlights their first patient dosed, aiming to preserve pancreatic beta cells in newly diagnosed individuals. This diabetes research offers significant hope for the type 1 diabetes community.

Видео This New Type 1 Treatment Might Actually Work канала Type-1 Diabetic Warriors